Oxidation-Reduction Agent
- Name
- Oxidation-Reduction Agent
- Accession Number
- DBCAT003567
- Description
Not Available
- Drugs
Drug Drug Description Methylthioninium The phenothiazine cation in methylene blue commonly used to treat methemoglobinemia. Methylene blue An oxidation-reduction agent used for the treatment of pediatric and adult patients with acquired methemoglobinemia. Omaveloxolone A semisynthetic triterpenoid used to treat Friedreich’s ataxia in adults and adolescents 16 years and older. - Drugs & Drug Targets